Suite 410-103 East Holly Street
Bellingham, WA 98225
Telephone: (360) 306 1133
Fax: (360) 230-7304
› Back
› Home
› Contact
Contact
Welcome
Caleco Pharma
Mission
Structure
Management
Strategic Partnerships
Health Products
Nutritional suplements
Lamiridosin - EU
R + D
Dermatologic Products
Hair Products
Drug Development
Scientific
Stock News
News
Investors
Health Products > Products > lamiriConditioner
LamiriCONDITIONER
Topical treatment for use with the shampoo.
A New Audio Interview with Jim Sandino of Caleco Pharma Corp.
Market Demand for Caleco's Liver Health Formulation (Marketwire)
› more
Tue, 23 Feb 2010
CALECO PHARMA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur (EDGAR Online)
› more
Mon, 22 Feb 2010
Laboratory Facilities and Service Agreement Signed by Caleco Pharma Corp. (Marketwire)
› more
Thu, 18 Feb 2010
CALECO PHARMA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob (EDGAR Online)
› more
Tue, 16 Feb 2010
Caleco Pharma Provides Corporate Update (Marketwire)
› more
Tue, 16 Feb 2010
Caleco Pharma Corp. Announces Entry Into Share Purchase Agreement With Natac Biotech S.L. (Marketwire)
› more
Wed, 10 Feb 2010
CALECO PHARMA CORP. Files SEC form 10-K, Annual Report (EDGAR Online)
› more
Tue, 9 Feb 2010
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant (Marketwire)
› more
Tue, 9 Feb 2010
CALECO PHARMA CORP. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial S (EDGAR Online)
› more
Thu, 21 Jan 2010
Caleco Pharma Corp. Announces Corporate Alliance With Rearden Health Partners (Marketwire)
› more
Thu, 21 Jan 2010
|
Welcome
|
Caleco Pharma
|
Health Products
|
Drug Development
|
Health Products
|
Drug Development
|
Scientific
|
News
|
Investors
|
Contacts
|
Caleco Pharma Corp. All Content Copyright 2009 All Rights Reserved.
Optimized for | The website was created in 0.48497 seconds.